| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/21/2011 | CN102188693A Novel proteoglycan complex |
| 09/21/2011 | CN102188658A Chinese medicine preparation for treating essence and blood deficiency for kidney-yin deficiency patients, preparation method thereof and application thereof |
| 09/21/2011 | CN102188547A Detoxification particle containing isatis root and coptis chinensis and preparation method thereof |
| 09/21/2011 | CN102188444A Method for building hypoxia and anoxia model by utilizing sodium sulfite as well as hypoxia and anoxia model |
| 09/21/2011 | CN101343250B Thrombopoietin mimetics |
| 09/21/2011 | CN101167774B Ginseng and American ginseng different parts extraction and its application for poultry and livestock |
| 09/20/2011 | US8022087 Derivatives of pyridone and use thereof |
| 09/20/2011 | US8022065 Purine derivatives as kinase inhibitors |
| 09/20/2011 | US8022044 Compositions and methods for therapeutic use |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8021876 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 09/20/2011 | US8021853 Inhibition of the β3 subunit of L-type Ca2+ channels |
| 09/20/2011 | CA2657106C Aminoindane derivative or salt thereof |
| 09/20/2011 | CA2589146C Process for producing muscarine receptor antagonist and intermediate therefor |
| 09/20/2011 | CA2560523C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 09/20/2011 | CA2509225C Indol derivatives and their use as 5-ht ligands |
| 09/20/2011 | CA2482637C New esters of hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| 09/20/2011 | CA2476619C Pet food composition for skin photoprotection |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2471578C Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments |
| 09/20/2011 | CA2467774C Solubilized topoisomerase poisons |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2458210C Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar-activators |
| 09/20/2011 | CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 09/20/2011 | CA2455328C New use of cyclolignans and new cyclolignans |
| 09/20/2011 | CA2443403C 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
| 09/20/2011 | CA2439415C Cathepsin cysteine protease inhibitors |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2225796C Novel formulation for peptide release |
| 09/20/2011 | CA2223573C Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011112956A1 Agonist/antagonist compositions and methods of use |
| 09/15/2011 | WO2011112002A2 Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient |
| 09/15/2011 | WO2011111817A1 Benzazepine compound |
| 09/15/2011 | WO2011111738A1 Novel fki-4429 substance and method for producing same |
| 09/15/2011 | WO2011111715A1 Nucleic acid capable of regulating cell cycle |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011111675A1 Novel indole derivative |
| 09/15/2011 | WO2011111581A1 Therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury |
| 09/15/2011 | WO2011111384A1 Transdermal composition containing therapeutic agent for parkinson's disease |
| 09/15/2011 | WO2011110241A1 Immunogenic composition comprising s. pneumoniae polysaccharides conjugated to carrier proteins |
| 09/15/2011 | WO2011069921A9 Sucrose octasulfates of zinc, the preparation of same and the pharmaceutical and cosmetic uses thereof |
| 09/15/2011 | WO2011012609A3 Anti - tgf - beta receptor type ii single domain antibodies |
| 09/15/2011 | WO2010132038A3 A formulation and method for relieving or preventing symptoms associated with uric acid crystals |
| 09/15/2011 | US20110225676 Two Novel Alkylresorcinol Synthase Genes from Sorghum; Cloning, Expression, Transformation and Characterization |
| 09/15/2011 | US20110225664 Meganuclease variants cleaving a dna target sequence from a glutamine synthetase gene and uses thereof |
| 09/15/2011 | US20110224311 Natural Product Sweetness Enhancers |
| 09/15/2011 | US20110224298 Diene compounds for use in human epidermal cell repair and pharmaceutical and cosmetic compositions containing them |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224255 Tripeptidyl peptidase inhibitors |
| 09/15/2011 | US20110224253 Small-molecule inhibitors of the androgen receptor |
| 09/15/2011 | US20110224251 Therapeutic Pyrazolyl Thienopyridines |
| 09/15/2011 | US20110224248 Azaquinolones that inhibit prolyl hydroxylase |
| 09/15/2011 | US20110224221 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors |
| 09/15/2011 | US20110224200 Therapeutic agent for chorioretinal degenerative disease containing pyridine-3-carbaldehyde 0-(piperidin-1-yl-propyl)-oxime derivative as active ingredient |
| 09/15/2011 | US20110224194 Staurosporine Derivatives as Inhibitors of FLT3 Receptor Tyrosine Kinase Activity |
| 09/15/2011 | US20110224169 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 09/15/2011 | US20110224166 COMPOSITION FOR ACTIVATING MITOCHONDRIA (As Amended) |
| 09/15/2011 | US20110224157 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 09/15/2011 | US20110224143 Nucleobindin i variant protein compositions and methods of use |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223267 Compositions of bakuchiol and methods of making the same |
| 09/15/2011 | US20110223225 Solid oil powders |
| 09/15/2011 | US20110223210 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 09/15/2011 | US20110223209 Oxygen delivering scaffold for tissue engineering |
| 09/15/2011 | US20110223167 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 09/15/2011 | US20110223149 Peptidomimetic macrocycles |
| 09/15/2011 | US20110223147 Lysosomal targeting peptides and uses thereof |
| 09/15/2011 | US20110223143 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same |
| 09/15/2011 | US20110223142 Methods and compositions for soft tissue repair |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223138 Mesenchymal stem cells that express increased amounts of anti-apoptotic proteins |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223111 Calcium carbonate microstructures useful in encapsulation applications and a process for the preparation thereof |
| 09/15/2011 | US20110223102 Multimodality agents for tumor imaging and therapy |
| 09/15/2011 | CA2792918A1 Benzazepine compound |
| 09/15/2011 | CA2792878A1 Agonist/antagonist compositions and methods of use |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/15/2011 | CA2791915A1 Immunogenic composition comprising s. pneumoniae polysaccharides conjugated to carrier proteins |
| 09/14/2011 | EP2365085A1 Growth hormone fusion protein |
| 09/14/2011 | EP2365061A1 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same |
| 09/14/2011 | EP2365004A2 Membrane associated tumor endothelium markers |
| 09/14/2011 | EP2364997A2 Polypeptide variants with altered effector function |
| 09/14/2011 | EP2364994A1 Purfied primate CTLA-8 antigens and related reagents |
| 09/14/2011 | EP2364990A1 Modulators of pharmacological agents |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364734A1 Multi-component biological transport systems |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2364706A1 Pharmaceutical agent comprising quinolone compound |
| 09/14/2011 | EP2364705A2 Modulators of muscarinic receptors |
| 09/14/2011 | EP2364296A1 Pyrrolidines |
| 09/14/2011 | EP2049664B1 Single stranded oligonucleotides complementary to repetitive elements for treating DNA repeat instability associated genetic disorders |
| 09/14/2011 | EP1740535B1 Thio-substituted arylmethanesulfinyl derivatives |
| 09/14/2011 | EP1559716B1 Pyrazolonaphthyridine derivative |
| 09/14/2011 | EP1471915B1 2,4-pyrimidinediamine compounds and their uses |
| 09/14/2011 | EP1446401B1 C5-modified indazolylpyrrolotriazines |
| 09/14/2011 | EP1445314B1 Novel glutamic acid receptor and utilization thereof |